Biopharmaceutical Contract Manufacturing Market Size And Share

  • Report Code : TIPRE00005512
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 211
Buy Now

Biopharmaceutical Contract Manufacturing Market Size, Top Players, and Forecast by 2028

Buy Now

Biopharmaceutical Contract Manufacturing Market Report Biopharmaceutical Contract Manufacturing Market Scope and Analysis Biopharmaceutical Contract Manufacturing Market Size and Share

Biopharmaceutical Contract Manufacturing Market: Strategic Insights

Biopharmaceutical Contract Manufacturing Market

  • CAGR (2021 - 2028)
    8.5%
  • Market Size 2021
    US$ 15.74 Billion
  • Market Size 2028
    US$ 27.87 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing demand for biologics and biosimilars production
  • Rising outsourcing trends in pharmaceutical manufacturing
FUTURE TRENDS
  • Shift towards more flexible and scalable manufacturing facilities
  • Rise of biopharmaceutical collaborations and partnerships
OPPORTUNITIES
  • Growth in demand for contract services in vaccine production
  • Expansion in emerging markets for contract manufacturing services

Key Players

  • Lonza AG
  • Boehringer Ingelheim Biopharmaceuticals GmbH
  • Inno Bio Ventures Sdn Bhd
  • Thermo Fisher Scientific Inc
  • AbbVie Inc
  • WuXi Biologics Inc
  • General Electric Co
  • Samsung Biologics Co Ltd
  • Merck KGaA

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Biologics and Biosimilar
Service
  • Process Development
  • Fill and Finish Operations
  • Analytical and Quality Control Studies
  • Packaging
Source
  • Mammalian and Microbial-Based Biologics/Non-Mammalian